MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 42 filers reported holding MYMD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,189 | -60.5% | 120,252 | 0.0% | 0.00% | – |
| Q2 2023 | $180,378 | -12.8% | 120,252 | 0.0% | 0.00% | – |
| Q1 2023 | $206,833 | -11.6% | 120,252 | -40.9% | 0.00% | – |
| Q4 2022 | $234,030 | -12.0% | 203,504 | +100.0% | 0.00% | – |
| Q3 2022 | $266,000 | +20.4% | 101,752 | 0.0% | 0.00% | – |
| Q2 2022 | $221,000 | -53.4% | 101,752 | 0.0% | 0.00% | – |
| Q1 2022 | $474,000 | -4.0% | 101,752 | +24.7% | 0.00% | – |
| Q4 2021 | $494,000 | -15.8% | 81,586 | 0.0% | 0.00% | – |
| Q3 2021 | $587,000 | +257.9% | 81,586 | +213.0% | 0.00% | – |
| Q2 2021 | $164,000 | – | 26,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |